Applying a Holistic Digital Endpoint Strategy in the Development of Congestive Heart Failure Treatments Webinar Replay

As the treatment modalities, scope, and complexity of clinical trials for congestive heart failure (CHF) drug development increase, so does the need for precision and accuracy in endpoint definitions and assessments.

Now available on-demand:

Dive into this comprehensive webinar that explores how to integrate cardiac imaging, ECG, and arrhythmia assessments with a meaningful patient-reported outcome strategy. This on-demand session is designed to optimize study outcomes, ensure data integrity, and support regulatory success.

Watch this on-demand webinar to gain insights into:

• Advanced cardiac monitoring techniques, including continuous arrhythmia assessment, blood pressure tracking, and the use of 12-lead ECG for characterizing cardiac function.
• Recent professional guidelines and trends regarding patient-reported outcomes in heart failure trials to assess symptom burden and quality of life accurately.
• The limitations of site-based echocardiography and the advantages of blinded central review, along with advanced modalities such as 3D echocardiography and cardiac MRI.
• The critical role of independent clinical adjudication in major adverse cardiovascular events (MACE) studies for achieving unbiased, regulator-grade endpoint classification.

Access this essential resource now to equip your clinical development teams with the scientific rationale and operational insights necessary to elevate the quality and impact of CHF clinical trials. Enhance data quality, support regulatory success, and improve outcomes in heart failure trials with a robust digital endpoint strategy.